321 related articles for article (PubMed ID: 10445752)
21. Molecular characterization of thyroid toxicity: anchoring gene expression profiles to biochemical and pathologic end points.
Glatt CM; Ouyang M; Welsh W; Green JW; Connor JO; Frame SR; Everds NE; Poindexter G; Snajdr S; Delker DA
Environ Health Perspect; 2005 Oct; 113(10):1354-61. PubMed ID: 16203246
[TBL] [Abstract][Full Text] [Related]
22. Effects of propylthiouracil and bromocryptine on serum concentrations of thyrotrophin and thyroid hormones in normal female horses.
Johnson PJ; Messer NT; Ganjam VK; Thompson DL; Refsal KR; Loch WE; Ellersieck MR
Equine Vet J; 2003 May; 35(3):296-301. PubMed ID: 12755434
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the hepatic and thyroid gland effects of sodium phenobarbital and pregnenolone-16α-carbonitrile in wild-type and constitutive androstane receptor (CAR)/pregnane X receptor (PXR) knockout rats.
Haines C; Chatham LR; Vardy A; Elcombe CR; Foster JR; Lake BG
Xenobiotica; 2019 Feb; 49(2):227-238. PubMed ID: 29424600
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of the male pubertal assay's ability to detect thyroid inhibitors and dopaminergic agents.
Marty MS; Crissman JW; Carney EW
Toxicol Sci; 2001 Mar; 60(1):63-76. PubMed ID: 11222874
[TBL] [Abstract][Full Text] [Related]
25. Dose-response examination of UDP-glucuronosyltransferase inducers and their ability to increase both TGF-beta expression and thyroid follicular cell apoptosis.
Kolaja KL; Klaassen CD
Toxicol Sci; 1998 Nov; 46(1):31-7. PubMed ID: 9928666
[TBL] [Abstract][Full Text] [Related]
26. Thyroid vascular conductance: differential effects of elevated plasma thyrotropin (TSH) induced by treatment with thioamides or TSH-releasing hormone.
Connors JM; Huffman LJ; Michalkiewicz M; Chang BS; Dey RD; Hedge GA
Endocrinology; 1991 Jul; 129(1):117-25. PubMed ID: 1905224
[TBL] [Abstract][Full Text] [Related]
27. Antithyroid effects of propylthiouracil and sulfamonomethoxine in rats and monkeys.
Takayama S; Aihara K; Onodera T; Akimoto T
Toxicol Appl Pharmacol; 1986 Feb; 82(2):191-9. PubMed ID: 2418534
[TBL] [Abstract][Full Text] [Related]
28. Enhanced rat Hershberger assay appears reliable for detection of not only (anti-)androgenic chemicals but also thyroid hormone modulators.
Yamada T; Kunimatsu T; Miyata K; Yabushita S; Sukata T; Kawamura S; Seki T; Okuno Y; Mikami N
Toxicol Sci; 2004 May; 79(1):64-74. PubMed ID: 14976338
[TBL] [Abstract][Full Text] [Related]
29. Effects of methylmercaptoimidazole (MMI), propylthiouracil (PTU), potassium perchlorate (KClO4) and potassium iodide (KI) on the serum concentrations of thyrotrophin (TSH) and thyroid hormones in the rat.
Männistö PT; Ranta T; Leppäluoto J
Acta Endocrinol (Copenh); 1979 Jun; 91(2):271-81. PubMed ID: 111448
[TBL] [Abstract][Full Text] [Related]
30. A mode of action for induction of thyroid gland tumors by Pyrethrins in the rat.
Finch JM; Osimitz TG; Gabriel KL; Martin T; Henderson WJ; Capen CC; Butler WH; Lake BG
Toxicol Appl Pharmacol; 2006 Aug; 214(3):253-62. PubMed ID: 16626768
[TBL] [Abstract][Full Text] [Related]
31. Thyroid hypertrophic effect of semotiadil fumarate, a new calcium antagonist, in rats.
Tsuchiya Y; Ohno H; Satoh H; Sugawara T; Kajimura T; Nomura M
J Toxicol Sci; 2000 May; 25(2):121-30. PubMed ID: 10845190
[TBL] [Abstract][Full Text] [Related]
32. Differential effects of microsomal enzyme-inducing chemicals on the hepatic expression of rat organic anion transporters, OATP1 and OATP2.
Rausch-Derra LC; Hartley DP; Meier PJ; Klaassen CD
Hepatology; 2001 Jun; 33(6):1469-78. PubMed ID: 11391536
[TBL] [Abstract][Full Text] [Related]
33. The effects of hepatic microsomal enzyme inducers on the pharmacokinetics of ouabain after portal and systemic administration to rats.
Thompson TN; Klaassen CD
J Pharm Pharmacol; 1995 Dec; 47(12A):1041-7. PubMed ID: 8932692
[TBL] [Abstract][Full Text] [Related]
34. UDP-glucuronosyltransferase inducers reduce thyroid hormone levels in rats by an extrathyroidal mechanism.
Barter RA; Klaassen CD
Toxicol Appl Pharmacol; 1992 Mar; 113(1):36-42. PubMed ID: 1553754
[TBL] [Abstract][Full Text] [Related]
35. p53-independent induction of rat hepatic Mdm2 following administration of phenobarbital and pregnenolone 16alpha-carbonitrile.
Nelson DM; Bhaskaran V; Foster WR; Lehman-McKeeman LD
Toxicol Sci; 2006 Dec; 94(2):272-80. PubMed ID: 17000718
[TBL] [Abstract][Full Text] [Related]
36. Effect of microsomal enzyme inducers on the biliary excretion of triiodothyronine (T(3)) and its metabolites.
Vansell NR; Klaassen CD
Toxicol Sci; 2002 Feb; 65(2):184-91. PubMed ID: 11812922
[TBL] [Abstract][Full Text] [Related]
37. The effects on rat thyroid function of an hepatic microsomal enzyme inducer.
Johnson S; McKillop D; Miller J; Smith IK
Hum Exp Toxicol; 1993 Mar; 12(2):153-8. PubMed ID: 8096714
[TBL] [Abstract][Full Text] [Related]
38. Effects of KClO4 in propylthiouracil-hypothyroid rats.
Ortiz-Caro J; Pastor RM; Jolin T
Acta Endocrinol (Copenh); 1983 May; 103(1):81-7. PubMed ID: 6305078
[TBL] [Abstract][Full Text] [Related]
39. Increase in rat liver UDP-glucuronosyltransferase mRNA by microsomal enzyme inducers that enhance thyroid hormone glucuronidation.
Vansell NR; Klaassen CD
Drug Metab Dispos; 2002 Mar; 30(3):240-6. PubMed ID: 11854140
[TBL] [Abstract][Full Text] [Related]
40. Effects of cytochrome P450 inducers on I-compounds in rat liver and kidney DNA.
Li D; Moorthy B; Chen S; Randerath K
Carcinogenesis; 1992 Jul; 13(7):1191-8. PubMed ID: 1638686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
